Altre lingue Jacobio Pharmaceuticals Group Co., Ltd.

Azioni

1167

KYG4987A1094

Mercato chiuso - Hong Kong S.E. Altri mercati azionari 10:08:16 02/05/2024			Variaz. 5gg	Var. 1 gen.
1,96 ^HKD	+15,98%		+34,25%	-45,86%

01/05	Jacobio Pharma annuncia che il suo inibitore di KRAS G12C ha raggiunto l'endpoint primario	CI
25/04	Jacobio Pharmaceuticals pianifica un cambio di revisore contabile	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Jacobio Pharma Announces Its KRAS G12C Inhibitor Reached the Primary Endpoint	01/05
Jacobio Pharmaceuticals Plans Auditor Change	25/04
Jacobio to Share Clinical Data of Anti-Tumor Drugs at US Convention	09/04
Jacobio Pharma to Present Data of PARP7 Inhibitor and P53 Reactivator at the 2024 AACR Annual Meeting	09/04
Jacobio Pharmaceuticals Narrows 2023 Loss on Lower R&D Expenses	01/04
Jacobio Pharmaceuticals Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Jacobio Pharmaceuticals Gets US FDA Clearance for Phase 1/2 Clinical Trial for Anti-Tumor Drug; Shares Surge 16%	01/03
Jacobio Pharmaceuticals Group Co., Ltd. Receives US FDA Investigational New Drug Clearance for P53 Y220C Activator JAB-30300	01/03
Hong Kong Stocks Fall as Chinese Central Bank Leaves Key Policy Rate on Hold; Jacobio Falls 11% Despite Drug Progress	19/02
China Approves Jacobio's Phase 3 Trial of Non-Small Cell Lung Cancer Drug; Shares Plummet 13%	19/02
Jacobio Pharma Announces China CDE Clearance for Phase III Clinical Trial of SHP2 Inhibitor Plus KRAS G12C Inhibitor	18/02
Jacobio Presents Clinical Data on Pancreatic Cancer Treatment at Oncology Meet; Shares Fall 7%	22/01
Jacobio Pharma Presents Data of Glecirasib in Patients with Pancreatic Cancer and Other Solid Tumors At the 2024 ASCO GI	19/01
Jacobio to Present Clinical Results of Pancreatic Cancer Drug in US Meet; Shares Jump 3%	07/12
Jacobio Pharmaceuticals Group Co., Ltd. Announces Clinical Results in the Oral Abstract Session of Clinical Oncology Gastrointestinal Cancers Symposium	07/12
Jacobio Presents Clinical Data on Anti-Tumor Drug at Oncology Congress	24/10/23
Jacobio Pharma Presents Clinical Results of Glecirasib in Combination with Jab-3312 At Esmo	22/10/23
Jacobio Pharmaceuticals Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	30/08/23
China Grants Breakthrough Therapy Status to Jacobio's Pancreatic Cancer Treatment; Shares Rise 5%	08/08/23
Jacobio Pharmaceuticals Group Co., Ltd.'S In-House KRAS G12C Inhibitor Jab-21822 Granted Breakthrough Therapy Designation for Pancreatic Cancer Patients	07/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Jacobio Pharmaceuticals Group Co., Ltd.

Azioni

1167

KYG4987A1094

Altre lingue

Filtri